Acrivon Therapeutics, Inc. Common Stock Share Price
NASDAQ: ACRVHealthcare
Live Acrivon Therapeutics, Inc. Common Stock Share Price Chart
O H L
Acrivon Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$1.70Low
$1.70High
Markets Today
| Previous Close | $1.70 |
|---|---|
| Open | $1.70 |
| Volume | 69,308 |
| Day's Range | $1.70 - $1.70 |
| 52W Range | $1.27 - $3.56 |
| Market Cap | $72.85 M |
Historical Performance
| 1M Returns | -17.07 |
|---|---|
| 3M Returns | +8.28 |
| 6M Returns | +3.66 |
| 1Y Returns | +1.80 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Acrivon Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $72.85 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-1.89 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.84 |
| EBITDA | $-82.76 M |
| Profit Margin | N/A |
| Market Cap | $72.85 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-1.89 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.84 |
| EBITDA | $-82.76 M |
| Profit Margin | N/A |
Acrivon Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$21.66 M | -$22.65 M | -$19.69 M | -$20.12 M | -$19.90 M | -$18.67 M |
| EBITDA | -$21.35 M | -$22.31 M | -$19.34 M | -$19.75 M | -$19.52 M | -$18.26 M |
| Interest Expense | $2.00 M | $0 | $0 | $0 | $989.00 K | $0 |
| Depreciation | $311.00 K | $335.00 K | $349.00 K | $361.00 K | $383.00 K | $405.00 K |
| Income Before Tax | -$19.68 M | -$21.01 M | -$18.23 M | -$18.98 M | -$19.04 M | -$17.96 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$19.68 M | -$21.01 M | -$18.23 M | -$18.98 M | -$19.04 M | -$17.96 M |
| Net Profit Margin | - | - | - | - | - | - |
Acrivon Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $31.00 K | $31.00 K | $31.00 K | $31.00 K | $38.00 K | $42.00 K |
| Reserve & Surplus | -$216.37 M | -$237.56 M | -$255.78 M | -$274.77 M | -$293.92 M | -$311.92 M |
| Non-Current Liabilities | $2.41 M | $2.12 M | $1.80 M | $1.54 M | $1.26 M | $980.00 K |
| Current Liabilities | $13.55 M | $13.43 M | $14.89 M | $15.66 M | $11.05 M | $11.45 M |
| Total Liabilities | $15.96 M | $15.55 M | $16.70 M | $17.20 M | $12.32 M | $12.43 M |
| Fixed Assets | $4.68 M | $5.07 M | $5.19 M | $4.89 M | $4.65 M | $4.25 M |
| Current Assets | $151.33 M | $138.41 M | $130.36 M | $120.44 M | $99.22 M | $91.49 M |
| Total Assets | $176.35 M | $158.58 M | $145.30 M | $129.72 M | $107.83 M | $99.09 M |
Acrivon Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$19.68 M | -$21.01 M | -$18.23 M | -$18.98 M | -$19.04 M | -$17.96 M |
| Operating Cash Flow | -$19.54 M | -$16.61 M | -$12.28 M | -$15.24 M | -$20.54 M | -$14.86 M |
| Investing Cash Flow | $19.21 M | $19.45 M | $5.91 M | $21.52 M | $13.13 M | $14.95 M |
| Financing Cash Flow | -$343.00 K | -$97.00 K | -$117.00 K | -$192.00 K | -$33.00 K | $7.27 M |
| Change in Cash | -$664.00 K | $2.74 M | -$6.49 M | $6.09 M | -$7.44 M | $7.35 M |
Acrivon Therapeutics, Inc. Common Stock Return Calculator
The Acrivon Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.
Popular Stocks
FAQs
What is the share price of Acrivon Therapeutics, Inc. Common Stock today?
Acrivon Therapeutics, Inc. Common Stock (ACRV) share price as of September 18, 2026 is $1.69. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Acrivon Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Acrivon Therapeutics, Inc. Common Stock (ACRV) Share by opening an international trading account with Angel One.
How can I purchase Acrivon Therapeutics, Inc. Common Stock shares in India?
Purchasing Acrivon Therapeutics, Inc. Common Stock (ACRV) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Acrivon Therapeutics, Inc. Common Stock (ACRV) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Acrivon Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Acrivon Therapeutics, Inc. Common Stock (ACRV) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Acrivon Therapeutics, Inc. Common Stock?
The market capitalization of Acrivon Therapeutics, Inc. Common Stock on September 18, 2026, is $72.85 M.
In which sector Acrivon Therapeutics, Inc. Common Stock belongs?
Acrivon Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Acrivon Therapeutics, Inc. Common Stock stocks?
In order to invest in Acrivon Therapeutics, Inc. Common Stock (ACRV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
